An inflammatory Signature of Glucose Impairment in Cystic Fibrosis

References

• Cystic Fibrosis Foundation. Cystic fibrosis foundation patient registry, 2019 annual data report and ECFSPR annual report; 2018.
   Google Scholar
• Kotnala S, Dhasmana A, Kashyap VK, Chauhan SC, Yallapu MM, Jaggi M. A bird eye view on cystic fibrosis: an underestimated multifaceted chronic disorder. Life Sci. 2021;268:118959. doi:10.1016/j.lfs.2020.118959
   PubMed Web of Science ®Google Scholar
• Morrison CB, Markovetz MR, Ehre C. Mucus, mucins, and cystic fibrosis. Pediatr Pulmonol. 2021;54(S3). doi:10.1002/ppul.24530
   Web of Science ®Google Scholar
• Turcios NL. Cystic fibrosis lung disease: an overview. Respir Care. 2020;65(2):233–251. doi:10.4187/respcare.06697
   PubMed Web of Science ®Google Scholar
• Moran A, Pillay K, Becker D, Granados A, Hameed S, Acerini CL. ISPAD clinical practice consensus guidelines 2018: management of cystic fibrosis-related diabetes in children and adolescents. Pediatr Diabetes. 2018;19:64–74. doi:10.1111/pedi.12732
   PubMed Web of Science ®Google Scholar
• Davis PB. Cystic Fibrosis. Pediatr Rev. 2001;22(8):257–264. doi:10.1542/pir.22-8-257
   PubMedGoogle Scholar
• Bogdani M, Blackman SM, Ridaura C, Bellocq J-P, Powers AC, Aguilar-Bryan L. Structural abnormalities in islets from very young children with cystic fibrosis may contribute to cystic fibrosis-related diabetes. Sci Rep. 2017;7(1):17231. doi:10.1038/s41598-017-17404-z
   PubMed Web of Science ®Google Scholar
• Hart NJ, Aramandla R, Poffenberger G, et al. Cystic fibrosis-related diabetes is caused by islet loss and inflammation. JCI Insight. 2018;3(8):e98240. doi:10.1172/jci.insight.98240
   PubMed Web of Science ®Google Scholar
• Kelsey R, Manderson Koivula FN, McClenaghan NH, Kelly C. Cystic fibrosis–related diabetes: pathophysiology and therapeutic challenges. Clin Med Insights Endocrinol Diabetes. 2019;12:117955141985177. doi:10.1177/1179551419851770
   Web of Science ®Google Scholar
• Doan LV, Madison LD. Cystic Fibrosis Related Diabetes. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2021.
   Google Scholar
• Chen GY, Nuñez G. Sterile inflammation: sensing and reacting to damage. Nat Rev Immunol. 2010;10(12):826–837. doi:10.1038/nri2873
   PubMed Web of Science ®Google Scholar
• Hunt WR, Hansen JM, Stecenko AA. Glucose ingestion in cystic fibrosis induces severe redox imbalance: a potential role in diabetes. J Cyst Fibros. 2020;19(3):476–482. doi:10.1016/j.jcf.2020.02.010
   PubMed Web of Science ®Google Scholar
• Sajadi S, Khoramdelazad H, Hassanshahi G, et al. Plasma Levels of CXCL1 (GRO-α) and CXCL10 (IP-10) are elevated in type 2 diabetic patients: evidence for the involvement of inflammation and angiogenesis/angiostasis in this disease state. Clin Lab. 2013;59. doi:10.7754/Clin.Lab.2012.120225
   PubMed Web of Science ®Google Scholar
• Omatsu T, Cepinskas G, Clarson C, et al. CXCL1/CXCL8 (GROα/IL-8) in human diabetic ketoacidosis plasma facilitates leukocyte recruitment to cerebrovascular endothelium in vitro. Am J Physiol. 2014;306(9):E1077–84. doi:10.1152/ajpendo.00659.2013
   Web of Science ®Google Scholar
• Meyer N, Nuss SJ, Siebenhüner A, Akdis CA, Menz G, Rothe T. Differential serum protein markers and the clinical severity of asthma. JAA. 2014;67. doi:10.2147/JAA.S53920
   Google Scholar
• Wheeler KC, Jena MK, Pradhan BS, et al. VEGF may contribute to macrophage recruitment and M2 polarization in the decidua. PLoS One. 2018;13(1):e0191040. doi:10.1371/journal.pone.0191040
   PubMed Web of Science ®Google Scholar
• Sun X, Zhang H, Liu J, Wang G. Serum vascular endothelial growth factor level is elevated in patients with impaired glucose tolerance and type 2 diabetes mellitus. J Int Med Res. 2019;47(11):5584–5592. doi:10.1177/0300060519872033
   PubMed Web of Science ®Google Scholar
• Lamoke F, Labazi M, Montemari A, Parisi G, Varano M, Bartoli M. Trans-Chalcone prevents VEGF expression and retinal neovascularization in the ischemic retina. Exp Eye Res. 2011;93(4):350–354. doi:10.1016/j.exer.2011.02.007
   PubMed Web of Science ®Google Scholar
• Compernolle V, Brusselmans K, Acker T, et al. Loss of HIF-2α and inhibition of VEGF impair fetal lung maturation, whereas treatment with VEGF prevents fatal respiratory distress in premature mice. Nat Med. 2002;8(7):702–710. doi:10.1038/nm721
   PubMed Web of Science ®Google Scholar
• Al-Husseini A, Kraskauskas D, Mezzaroma E, et al. Vascular endothelial growth factor receptor 3 signaling contributes to angioobliterative pulmonary hypertension. Pulm Circ. 2015;5(1):101–116. doi:10.1086/679704
   PubMed Web of Science ®Google Scholar
• Akturk HK, Kahramangil D, Sarwal A, Hoffecker L, Murad MH, Michels AW. Immune checkpoint inhibitor‐induced Type 1 diabetes: a systematic review and meta‐analysis. Diabet Med. 2019;36(9):1075–1081. doi:10.1111/dme.14050
   PubMed Web of Science ®Google Scholar
• Colli ML, Hill JLE, Marroquí L, et al. PDL1 is expressed in the islets of people with type 1 diabetes and is up-regulated by interferons-α and-γ via IRF1 induction. EBioMedicine. 2018;36:367–375. doi:10.1016/j.ebiom.2018.09.040
   PubMed Web of Science ®Google Scholar
• Geng Y, Liu X, Liang J, et al. PD-L1 on invasive fibroblasts drives fibrosis in a humanized model of idiopathic pulmonary fibrosis. JCI Insight. 2019. doi:10.1172/jci.insight.125326
   Web of Science ®Google Scholar
• Yuan S, Zhang S, Zhuang Y, Zhang H, Bai J, Hou Q. Interleukin-17 stimulates STAT3-mediated endothelial cell activation for neutrophil recruitment. Cell Physiol Biochem. 2015;36(6):2340–2356. doi:10.1159/000430197
   PubMedGoogle Scholar
• Song TL, Nairismägi M-L, Laurensia Y, et al. Oncogenic activation of the STAT3 pathway drives PD-L1 expression in natural killer/T-cell lymphoma. Blood. 2018;132(11):1146–1158. doi:10.1182/blood-2018-01-829424
   PubMed Web of Science ®Google Scholar
• Hwang S, Seong H, Ryu J, et al. Phosphorylation of STAT3 and ERBB2 mediates hypoxia‑induced VEGF release in ARPE‑19 cells. Mol Med Rep. 2020. doi:10.3892/mmr.2020.11344
   Web of Science ®Google Scholar
• Kohan M, Puxeddu I, Reich R, Levi-Schaffer F, Berkman N. Eotaxin-2/CCL24 and eotaxin-3/CCL26 exert differential profibrogenic effects on human lung fibroblasts. Ann Allergy Asthma Immunol. 2010;104(1):66–72. doi:10.1016/j.anai.2009.11.003
   PubMed Web of Science ®Google Scholar
• Van Dyke AL, Lang Kuhs KA, Shiels MS, et al. Associations between self-reported diabetes and 78 circulating markers of inflammation, immunity, and metabolism among adults in the United States. PLoS One. 2017;12(7):e0182359. doi:10.1371/journal.pone.0182359
   PubMed Web of Science ®Google Scholar
• Coomans de Brachène A, Dos Santos RS, Marroqui L, et al. IFN-α induces a preferential long-lasting expression of MHC class I in human pancreatic beta cells. Diabetologia. 2018;61(3):636–640. doi:10.1007/s00125-017-4536-4
   PubMed Web of Science ®Google Scholar
• Shan Z, Xu C, Wang W, Li W. Enhanced PDGF signaling in gestational diabetes mellitus is involved in pancreatic β-cell dysfunction. Biochem Biophys Res Commun. 2019;516(2):402–407. doi:10.1016/j.bbrc.2019.06.048
   PubMed Web of Science ®Google Scholar
• Lam GY, Goodwin J, Wilcox PG, Quon BS. Sex disparities in cystic fibrosis: review on the effect of female sex hormones on lung pathophysiology and outcomes. ERJ Open Res. 2021;7(1):00475–2020. doi:10.1183/23120541.00475-2020
   PubMedGoogle Scholar